Skip to main content
Cancer Immunology, Immunotherapy : CII logoLink to Cancer Immunology, Immunotherapy : CII
. 1984 Sep;17(3):160–164. doi: 10.1007/BF00205480

Peripheral Tγ lymphocyte population in head and neck cancer

Yoshio Hayashi 1,, Toshinobu Nishida 1, Hideo Yoshida 2, Tetsuo Yanagawa 2, Yoshiaki Yura 2, Nanayo Furumoto 2, Mitsunobu Sato 2
PMCID: PMC11039151  PMID: 6236876

Abstract

Peripheral Tγ lymphocytes were measured in head and neck cancer patients and controls. The percentage was significantly higher in the 59 cancer patients than in the 46 normal controls (P<0.001). The 12 patients with recurrent disease had elevated percentages of Tγ lymphocytes compared with the untreated group (n=31; P<0.05) and the treated, disease-free group (n=16; P<0.05). Moreover, the percentage of Tγ lymphocytes was significantly higher in the 31 patients with regional lymph node metastasis than in the node-negative group (n=28; P<0.05). In a total of 37 patients with squamous cell carcinoma histologically graded I, II, and III, the absolute counts and percentages of Tγ lymphocytes in the grade I group (n=13) showed significant decreases compared with those in the grade III group (P<0.05; n=6). Moreover, postoperative serial determinations of the percentage of Tγ lymphocytes in the 14 treated, disease-free patients revealed a gradual decrease of Tγ lymphocytes, whereas the five patients with recurrent disease had a tendency to increases in the percentage of Tγ lymphocytes.

Keywords: Cancer Patient, Lymph Node Metastasis, Squamous Cell Carcinoma, Squamous Cell, Normal Control

Footnotes

Abbreviations used in this paper: SMF, sodium metrizoate-Ficoll; PBS, phosphate-buffered saline; SRBC, sheep erythrocytes; FCS, fetal calf serum; Hepes, hydroxyethylpiperazin elthene-sulfonic acid; E, erythrocyte; EAC, erythrocyte-antibody-complement; K, antibody-dependent killer; NK, natural killer

References

  • 1.Anderson LC, Nilsson K, Gahmberg CG. K 562 — A human erythroleukemic cell line. Int J Cancer. 1979;23:143. doi: 10.1002/ijc.2910230202. [DOI] [PubMed] [Google Scholar]
  • 2.Berlinger N, Hital EY, Oettgen HF, Good RA. Deficient cell-mediated immunity in head and neck cancer patients secondary to autologous suppressive immune cells. Laryngoscope. 1978;88:470. doi: 10.1288/00005537-197803000-00011. [DOI] [PubMed] [Google Scholar]
  • 3.Biberfeld P, Wahlin B, Perlman P, Biberfeld G. A plaque technique for assay and characterization of antibody-dependent cytotoxic effector (K) cells. Scand J Immunol. 1975;23:143. doi: 10.1111/j.1365-3083.1975.tb03729.x. [DOI] [PubMed] [Google Scholar]
  • 4.Breard J, Reinherz EL, Kung PC, Goldstein G, Schlossman SF. A monoclonal antibody reactive with human peripheral blood monocytes. J Immunol. 1980;124:1943. [PubMed] [Google Scholar]
  • 5.Brown G, Greaves MF. Cell surface markers for human T and B lymphocytes. Eur J Immunol. 1974;4:32. doi: 10.1002/eji.1830040414. [DOI] [PubMed] [Google Scholar]
  • 6.Carlo JR, Ruddy S, Studer EJ, Conrad DH. Complement receptor binding of C3b-coated cell treated with C3b inactivation, β1H globulin and trypsin. J Immunol. 1979;123:523. [PubMed] [Google Scholar]
  • 7.Evrin PE, Peterson PA, Wide L, Berggård I. Radioimmunoassay of β2-microglobulin in human biological fluids. Scand J Clin Lab Invest. 1971;28:439. doi: 10.3109/00365517109095721. [DOI] [PubMed] [Google Scholar]
  • 8.Fast LD, Hansen JA, Newman W. Evidence for T cell nature and heterogeneity within natural killer (NK) and antibody-dependent cellular cytotoxicity (ADCC) effectors: A comparison with cytolytic T lymphocytes (CTL) J Immunol. 1981;127:448. [PubMed] [Google Scholar]
  • 9.Froland SS, Wisloff F, Michaelsen TE. Human lymphocytes with receptors for IgG. A population of cells distinct from T and B lymphocytes. Int Arch Allergy Appl Immunol. 1974;47:124. doi: 10.1159/000231207. [DOI] [PubMed] [Google Scholar]
  • 10.Gmelig-Meyling F, Ballieux RE. Simplified procedure for the separation of human T and non-T cells. Vox Sang. 1977;33:5. doi: 10.1111/j.1423-0410.1977.tb02229.x. [DOI] [PubMed] [Google Scholar]
  • 11.Hilal E, Wanebo HJ, Pinsky CF, Middleman P, Strong EW, Oettgen HF. Immunologic evaluation and prognosis in patients with head and neck cancer. Am J Surg. 1977;134:469. doi: 10.1016/0002-9610(77)90380-4. [DOI] [PubMed] [Google Scholar]
  • 12.Jenels TR, Dean HJ, Richardson GL, McCoy JL. Role of suppressor cells in depression of in vitro lympho-proliferative responses of lung cancer and breast cancer patients. J Natl Cancer Inst. 1978;61:1001. [PubMed] [Google Scholar]
  • 13.Kay HD, Bonnard GD, West WH, Herberman RB. A functional comparison of human Fc-receptor-bearing lymphocytes active in natural cytotoxicity and antibody-dependent cellular cytotoxicity. J Immunol. 1977;117:2058. [PubMed] [Google Scholar]
  • 14.Lay WH, Mendes NF. Binding of sheep red blood cells to a large population of human lymphocytes. Nature. 1971;230:531. doi: 10.1038/230531a0. [DOI] [PubMed] [Google Scholar]
  • 15.Moretta L, Ferrarini M, Mingari MC, Moretta A, Webb SR. Subpopulations of human T cells identified by receptors for immunoglobulins and mitogen responsiveness. J Immunol. 1976;117:2171. [PubMed] [Google Scholar]
  • 16.Moretta L, Webb SR, Crossi CE, Lydyard PM, Cooper MD. Functional analysis of two human T-cell subpopulations: Help and suppression of B-cell responses by T-cell-bearing receptors for IgM or IgG. J Exp Med. 1977;146:184. doi: 10.1084/jem.146.1.184. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Moretta L, Mingari MC, Moretta A, Cooper MD. Human T lymphocyte subpopulations: Studies of the mechanism by which T cells bearing Fc receptors for IgG suppress T-independent B cell differentiation induced by pokeweed mitogen. J Immunol. 1979;122:984. [PubMed] [Google Scholar]
  • 18.Pichler WJ, Lum L, Broder S. Fc-receptors on human T lymphocytes. I. Transition of Tγ to Tμ cells. J Immunol. 1978;121:1540. [PubMed] [Google Scholar]
  • 19.Pinsky C, Wanebo HJ, MikéV OH, Oettgen HF. Delayed cutaneous hypersensitivity reactions and prognosis in patients with cancer. Ann NY Acad Sci. 1976;276:407. doi: 10.1111/j.1749-6632.1976.tb41665.x. [DOI] [PubMed] [Google Scholar]
  • 20.Rao B, Wanebo HJ, Pinsky CM, Stearns M, Oettgen HF. Delayed hypersensitivity reactions in patients with carcinoma of the colon and rectum. Surg Gynecol Obset. 1977;144:677. [PubMed] [Google Scholar]
  • 21.Reinherz EL, Moretta L, Roper M, Breard JM, Mingari MC, Cooper MD, Schlossman SF. Human T lymphocyte subpopulation defined by Fc receptors and monoclonal antibodies. A comparison. J Exp Med. 1980;151:969. doi: 10.1084/jem.151.4.969. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Shaw S, Pichler WJ, Nelson DL. Fc receptors on human T-lymphocytes. III. Characterization of subpopulations involved in cell-mediated lympholysis and antibody-dependent cellular cytotoxicity. J Immunol. 1979;122:599. [PubMed] [Google Scholar]
  • 23.Theofilopoulos AN, Andrews BS, Urist MM, Morton DL, Dixon FJ. The nature of immune complexes in human cancer sera. J Immunol. 1977;119:657. [PubMed] [Google Scholar]
  • 24.Tilden AB, Abo T, Balch CM. Suppressor cell function on human granular lymphocytes identified by the HNK-1 (Leu7) monoclonal antibody. J Immunol. 1983;130:1171. [PubMed] [Google Scholar]
  • 25.Timonen T, Saksela E. A simplified isotope release assay for cell-mediated cytotoxicity against anchorage dependent target cells. J Immunol Methods. 1977;18:123. doi: 10.1016/0022-1759(77)90163-6. [DOI] [PubMed] [Google Scholar]
  • 26.Titus JA, Sharrow SO, Segal DM. Analysis of FCγ (IgG) receptors on human peripheral blood lymphocytes by dual fluorescence flow microfluorometry. II. Quantitation of receptors on cells that express the OKM1, OKT3, OKT4, and OKT8 antigens. J Immunol. 1983;130:1152. [PubMed] [Google Scholar]
  • 27.Wahi PN, Cohen B, Luthra UK, Torloni H. International histological classification of tumors, no. 4. Geneva: World Health Organization; 1971. Histological typing of oral and oropharyngeal tumors. [Google Scholar]
  • 28.Wanebo HJ, Pinsky CM, Beattie EJ, Oettgen HF. Immunocompetence testing in patients with one of the four common operable cancer — A review. Clin Bull. 1978;8:15. [PubMed] [Google Scholar]
  • 29.Winchester RJ, Hoffman T, Ferrarini M. Comparison of various tests for Fc receptors on different human lymphocytes subpopulation. Clin Exp Immunol. 1979;37:126. [PMC free article] [PubMed] [Google Scholar]

Articles from Cancer Immunology, Immunotherapy : CII are provided here courtesy of Springer

RESOURCES